The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

CEOs from European drugmakers Sanofi and Novartis have inked a letter in The Financial Times urging the European Union to set ...

April 24, 2025 Sanofi's quarterly profit boosted by Dupixent ... Tariff wars to hit popular US-made drugs in China, regulator data shows Popular Western medicines for diseases including cancer ...

Sanofi has launched Dupixent for COPD in eight countries, said Hudson, who added that 2025 will be the "inflection year," for the treatment in the indication. Related ...